Rhein Induces Oral Cancer Cell Apoptosis and ROS via Suppresse AKT/mTOR Signaling Pathway In Vitro and In Vivo

Oral cancer remains the leading cause of death worldwide. Rhein is a natural compound extracted from the traditional Chinese herbal medicine rhubarb, which has demonstrated therapeutic effects in various cancers. However, the specific effects of rhein on oral cancer are still unclear. This study aimed to investigate the potential anticancer activity and underlying mechanisms of rhein in oral cancer cells. The antigrowth effect of rhein in oral cancer cells was estimated by cell proliferation, soft agar colony formation, migration, and invasion assay. The cell cycle and apoptosis were detected by flow cytometry. The underlying mechanism of rhein in oral cancer cells was explored by immunoblotting. The in vivo anticancer effect was evaluated by oral cancer xenografts. Rhein significantly inhibited oral cancer cell growth by inducing apoptosis and S-phase cell cycle arrest. Rhein inhibited oral cancer cell migration and invasion through the regulation of epithelial–mesenchymal transition-related proteins. Rhein induced reactive oxygen species (ROS) accumulation in oral cancer cells to inhibit the AKT/mTOR signaling pathway. Rhein exerted anticancer activity in vitro and in vivo by inducing oral cancer cell apoptosis and ROS via the AKT/mTOR signaling pathway in oral cancer. Rhein is a potential therapeutic drug for oral cancer treatment.

[1]  Feng Wang,et al.  Inhibition of hypoxia‐induced HIF‐1α‐mediated autophagy enhances the in vitro antitumor activity of rhein in pancreatic cancer cells , 2022, Journal of applied toxicology : JAT.

[2]  Nelson E. Brown,et al.  mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership , 2021, International journal of molecular sciences.

[3]  Dan Li,et al.  Reactive Oxygen Species as a Link between Antioxidant Pathways and Autophagy , 2021, Oxidative medicine and cellular longevity.

[4]  A. Efeyan,et al.  The mTOR–Autophagy Axis and the Control of Metabolism , 2021, Frontiers in Cell and Developmental Biology.

[5]  Lei Li,et al.  OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer , 2020, Oncogene.

[6]  J. Haybaeck,et al.  Therapeutic Potential of PI3K/AKT/mTOR Pathway in Gastrointestinal Stromal Tumors: Rationale and Progress , 2020, Cancers.

[7]  Bo Li,et al.  Anti-cancer Effect of 20(S)-Ginsenoside-Rh2 on Oral Squamous Cell Carcinoma Cells via the Decrease in ROS and Downregulation of MMP-2 and VEGF. , 2020, Biomedical and environmental sciences : BES.

[8]  H. Zeng,et al.  Chronic stress promotes EMT-mediated metastasis through activation of STAT3 signaling pathway by miR-337-3p in breast cancer , 2020, Cell Death & Disease.

[9]  S. Dyshlovoy.  Blue-Print Autophagy in 2020: A Critical Review , 2020, Marine drugs.

[10]  M. Bin-Jumah,et al.  Anticancer natural medicines: An overview of cell signaling and other targets of anticancer phytochemicals. , 2020, European journal of pharmacology.

[11]  Tzu-Ying Lee,et al.  The Potential of Phytochemicals in Oral Cancer Prevention and Therapy: A Review of the Evidence , 2020, Biomolecules.

[12]  M. Do,et al.  Molecular mechanisms of methylglyoxal-induced aortic endothelial dysfunction in human vascular endothelial cells , 2020, Cell Death & Disease.

[13]  Do-Hee Kim,et al.  Thymoquinone induces apoptosis of human renal carcinoma Caki-1 cells by inhibiting JAK2/STAT3 through pro-oxidant effect. , 2020, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  P. Takáč,et al.  Antiproliferative Effect of Acridine Chalcone Is Mediated by Induction of Oxidative Stress , 2020, Biomolecules.

[15]  J. Chen,et al.  Rhein induces liver cancer cells apoptosis via activating ROS-dependent JNK/Jun/caspase-3 signaling pathway , 2020, Journal of Cancer.

[16]  Eun-Kyung Kim,et al.  Redox-Mediated Mechanism of Chemoresistance in Cancer Cells , 2019, Antioxidants.

[17]  S. Chu,et al.  Thymoquinone suppresses the proliferation of renal cell carcinoma cells via reactive oxygen species‐induced apoptosis and reduces cell stemness , 2019, Environmental toxicology.

[18]  Y. Zhuang,et al.  Rhein sensitizes human colorectal cancer cells to EGFR inhibitors by inhibiting STAT3 pathway , 2019, OncoTargets and therapy.

[19]  D. Green,et al.  Autophagy-Independent Functions of the Autophagy Machinery , 2019, Cell.

[20]  Yang Liu,et al.  Anemoside B4 exerts anti-cancer effect by inducing apoptosis and autophagy through inhibiton of PI3K/Akt/mTOR pathway in hepatocellular carcinoma. , 2019, American journal of translational research.

[21]  Weiling Li,et al.  Rhein Inhibits the Migration of Ovarian Cancer Cells through Down-Regulation of Matrix Metalloproteinases. , 2019, Biological & pharmaceutical bulletin.

[22]  Lehe Yang,et al.  Rhein shows potent efficacy against non-small-cell lung cancer through inhibiting the STAT3 pathway , 2019, Cancer management and research.

[23]  Lijuan Hu,et al.  Rhein enhances the cytotoxicity of effector lymphocytes in colon cancer under hypoxic conditions. , 2018, Experimental and therapeutic medicine.

[24]  M. Milella,et al.  Role of mTOR Signaling in Tumor Microenvironment: An Overview , 2018, International journal of molecular sciences.

[25]  Xiaoxv Dong,et al.  Rhein Induces Cell Death in HepaRG Cells through Cell Cycle Arrest and Apoptotic Pathway , 2018, International journal of molecular sciences.

[26]  Xin Shi,et al.  Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through the Akt/GSK3β signaling pathway in human cervical cancer cells. , 2018, Molecular medicine reports.

[27]  Junhua Zheng,et al.  Ginsenoside Rh2 inhibits prostate cancer cell growth through suppression of microRNA‐4295 that activates CDKN1A , 2018, Cell proliferation.

[28]  H. Cai,et al.  Ginsenoside Rh2 Inhibited Proliferation by Inducing ROS Mediated ER Stress Dependent Apoptosis in Lung Cancer Cells. , 2017, Biological & pharmaceutical bulletin.

[29]  P. Iribarren,et al.  Microtubule‐associated protein 1A/1B‐light chain 3 (LC3) ‘decorates’ intracytoplasmic inclusions in a patient with chronic lymphocytic leukaemia , 2017, British journal of haematology.

[30]  D. Zuo,et al.  Arsenic sulfide induces apoptosis and autophagy through the activation of ROS/JNK and suppression of Akt/mTOR signaling pathways in osteosarcoma , 2017, Free radical biology & medicine.

[31]  Weiqi Wang,et al.  The role of ROS and subsequent DNA-damage response in PUMA-induced apoptosis of ovarian cancer cells , 2017, Oncotarget.

[32]  César Rivera,et al.  Essentials of oral cancer. , 2015, International journal of clinical and experimental pathology.

[33]  T. Day,et al.  Oral cavity and oropharyngeal squamous cell carcinoma—an update , 2015, CA: a cancer journal for clinicians.

[34]  K. Rahman,et al.  Rhein: A Review of Pharmacological Activities. , 2015, Evidence-based complementary and alternative medicine : eCAM.

[35]  Marion Peyressatre,et al.  Targeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors , 2015, Cancers.

[36]  C. Jiang,et al.  Connecting endoplasmic reticulum stress to autophagy through IRE1/JNK/beclin-1 in breast cancer cells. , 2014, International journal of molecular medicine.

[37]  S. Yamada,et al.  N-cadherin as a key regulator of collective cell migration in a 3D environment , 2012, Cell adhesion & migration.

[38]  B. Zhivotovsky,et al.  Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and -independent apoptosis by stimulating ROS formation , 2012, Autophagy.

[39]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[40]  H. Kuwano,et al.  E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma , 2011, British Journal of Cancer.

[41]  A. Demain,et al.  Natural products for cancer chemotherapy , 2011, Microbial biotechnology.

[42]  N. M. Zaghloul,et al.  Expression of e-cadherin, n-cadherin and snail and their correlation with clinicopathological variants: an immunohistochemical study of 132 invasive ductal breast carcinomas in Egypt , 2011, Clinics.

[43]  Qinghua Zhou,et al.  上皮细胞间质化与肿瘤的转移 , 2011, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

[44]  Y. Zhen,et al.  Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice , 2009, Anti-cancer drugs.

[45]  A. Kortenkamp,et al.  Estrogens and genomic instability in human breast cancer cells--involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals. , 2008, Carcinogenesis.

[46]  P. Sutphin,et al.  A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. , 2008, Cancer cell.

[47]  Kevin Bray,et al.  Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. , 2006, Cancer cell.

[48]  J. Yook,et al.  Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells , 2005, Experimental & Molecular Medicine.

[49]  David Steven Scott,et al.  Regulation of the G1 phase of the mammalian cell cycle , 2000, Cell Research.

[50]  D. Sabatini,et al.  Leading Edge Review mTOR Signaling in Growth Control and Disease , 2013 .

[51]  D. Sabatini,et al.  mTOR Signaling. , 2012, Cold Spring Harbor perspectives in biology.

[52]  Daniel E. Johnson.  Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis. , 2008, Advances in enzyme regulation.

[53]  Robert K. Stuart,et al.  Oral cancer treatment , 2003, Current treatment options in oncology.